J
Jennifer J. Arnold
Publications - 4
Citations - 927
Jennifer J. Arnold is an academic researcher. The author has contributed to research in topics: Verteporfin & Choroidal neovascularization. The author has an hindex of 4, co-authored 4 publications receiving 901 citations.
Papers
More filters
Journal ArticleDOI
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1
Jennifer J. Arnold,D. Kilmartin,Jay A. Olson,S. Neville,K. Robinson,Angela R. Laird,C. Richmond,A. Farrow,S. McKay,David A. Saperstein,Thomas M. Aaberg,Joshua Johnson,R. Waldron,D. Loupe,J. Gillman,B. Myles,Andrew P. Schachat,Neil M. Bressler,Susan B. Bressler,P. Nesbitt,T. Porter,P. Hawse,Mary Elizabeth Hartnett,A. Eager,J. Belt,D. Cain,D. Emmert,T. George,M. Herring,J. McDonald,Jordi Monés,B. Corcostegui,M. Gilbert,N. Duran,M. Sisquella,A. Nolla,A. Margalef,Joan W. Miller,Evangelos S. Gragoudas,Anne Marie Lane,N. Emmanuel,A. Holbrook,Conor L. Evans,U. S. Lord,D. K. Walsh,C. D. Callahan,J. L. DuBois,Hilel Lewis,Peter K. Kaiser,L. J. Holody,E. Lesak,Susan Lichterman,H. Siegel,A. Fattori,G. Ambrose,T. Fecko,D. Ross,Shanna L. Burke,Lawrence J. Singerman,Hernando Zegarra,Michael A. Novak,M. Bartel,K. Tilocco-DuBois,M. Iic,S. Schura,S. J. Mayes,V. Tanner,P. Rowe,S. Smith-Brewer,D. Kukula,Gregg Greanoff,Geraldine Daley,John DuBois,D. Lehnhardt,Gary E. Fish,Bradley F. Jost,Rajiv Anand,David Callanan,Sally Arceneaux,J. Arnwine,P. Ellenich,J. King,Hank Aguado,R. Rollins,B. Jurklies,D. Pauleikhoff,A. Hintzmann,Michael Fischer,C. Sowa,E. Behne,Constantin J. Pournaras,Guy Donati,A. D. Kapetanios,K. Cavaliere,S. Guney-Wagner,N. Gerber,M. Sickenberg,V. Sickenberg,A. Gans,B. Hosner,A. Sbressa,C. Kozma,M. Curchod,S. A. Cancelli,Simon P. Harding,Y. C. Yang,M. C. Briggs,S. Briggs,V. Tompkin,R. Jackson,S. Pearson,S. Natha,J. Sharp,J. I. Lim,Christina J. Flaxel,M. Padilla,Leonard A. Levin,F. Walonker,L. Cisneros,T. Nichols,Ursula Schmidt-Erfurth,Irene Barbazetto,H. Laqua,R. Kupfer,R. Bulow,B. Glisovic,T. Bredfeldt,H. Elsner,V. Wintzer,D. Bahlmann,Stephan Michels,Mark S. Blumenkranz,Hunter L. Little,Robert L. Jack,L. M. Espiritu,L. Unyi,J. Regan,L. Lamborn,C. Silvestri,Robert H. Rosa,Philip J. Rosenfeld,Mary Lou Lewis,B. Rodriguez,A. Torres,N. Munoz,T. Contreras,M. Galvez,D. Hess,T. Cubillas,I. Rams,Jason S. Slakter,John A. Sorenson,P. A. Bruschi,Katherine Burke,E. Schnipper,Leandro Maranan,M. Scolaro,M. Riff,E. Agresta,I. Johansson,I. Dedorsson,S. Stenkula,C. Hvarfner,T. Carlsson,A. M. Liljedahl,S. Fallstrom,E. Jacobsson,Gisèle Soubrane,D. Kuhn,H. Oubraham,A. Benelhani,A. Kunsch,B. Delhoste,G. Ziverec,M. Lasnier,L. A. Lobes,Karl R. Olsen,B. J. Bahr,N. T. Worstell,L. A. Wilcox,L. A. Wellman,G. Vagstad,David M. Steinberg,Alan Campbell,Richard F. Dreyer,B. Williamson,Marvin Johnson,H. Crider,Raymond R. Margherio,George A. Williams,M. Zajechowski,C. Stanley,M. Kulak,P. Streasick,L. Szdlowski,R. Falk,S. Shoichet,G. Regan,P. Manatrey,K. Cumming,F. Koenig,Mustapha Benchaboune,K. Mezmate,S. Fontanay,Travis A. Meredith,J. Binning,J. Gualdoni,L. Boyd,E. Ort,B. Barts,Robert C. Allen,J. Dahl,T. Holle,P. T. Harvey,L. Kaus,D. Leuschner,S. Bolychuk,I. Hewitt,Ugo Menchini,Francesco Bandello,Gianni Virgili,Paolo Lanzetta,M. Ambesi,Angelo Pirracchio,Massimiliano Tedeschi,Michael J. Potter,B. Sahota,Lars Hall,Michael Stur,J. Lukas,Michael Tittl,S. Docker,K. Vogl,D. J. Pieramici,Kelly S Manos,R. Cooper,R. L. Denbow,E. R. Lowery,Dawn Phillips,S. K. Thibeault,Y. Tian,M. Harnett,N. Black,P. Escartin,D. Hartley,P. Haworth,T. Hecker,D. Hiscock,F. Jamali,N. Maradan,J. North,B. Norton,T. Stapleton-Hayes,Roy Taylor,G. Huber,J. Y. Deslandes,Mario Fsadni,I. Hess,H. de Pommerol,A. Bobillier,Reaves A,S. Banasik,John M Koester,Todd Gray,K. Truett,J. Baker,L. McAlister,R. Birch,A. Strong,M. Azab,N. Buskard,U. Manjuris,Y. Hao,M. Mason,U. McCurry,Reginald Birngruber,P. Harvey,J. M. Koester,C. Ma,Susan A. Murphy,S. Soubrane,Strong Ha,H. van den Berg,R. W. Beck,Alan C. Bird,Gabriel Coscas,A. Deutman,Lee M. Jampol,Ronald Klein,Maureen G. Maguire,P. Rosenfeld,R. P. Margherio,P. Staflin +292 more
TL;DR: Because photodynamic therapy with verteporfin can safely increase the chance of stabilizing or improving vision in patients with subfoveal CNV from pathologic myopia compared with a placebo, it is recommended ophthalmologists consider vertEPorfin therapy for treatment of such patients.
Journal ArticleDOI
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Neil M. Bressler,Jennifer J. Arnold,Mustapha Benchaboune,Mark S. Blumenkranz,Gary E. Fish,Evangelos S. Gragoudas,Hilel Lewis,Ursula Schmidt-Erfurth,Jason S. Slakter,Susan B. Bressler,Kelly S Manos,Yong Hao,Laurie Hayes,John M Koester,Reaves A,H. Andrew Strong +15 more
TL;DR: Initial reports that verteporfin therapy should be used to treat patients with AMD who have predominantly classic CNV, with or without occult CNV are supported, but it is suggested that further investigations should be performed to determine if lesions with a minimally classic composition might benefit when they are smaller and have lower levels of visual acuity.
Journal ArticleDOI
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
Jennifer J. Arnold,Kevin J. Blinder,Neil M. Bressler,Susan B. Bressler,Burdan A,Laurie Haynes,Jennifer I. Lim,Joan W. Miller,Michael J. Potter,Reaves A,Philip J. Rosenfeld,M. Sickenberg,Jason S. Slakter,Gisèle Soubrane,Strong Ha,Michael Stur +15 more
TL;DR: Acute severe visual acuity decrease after PDT with verteporfin was an uncommon event; the risk did not outweigh the benefits of therapy previously reported and patients should be warned of the possibility of this serious adverse event.
Journal ArticleDOI
Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis
TL;DR: A role for immunosuppressive therapy in the treatment of CNV associated with endogenous posterior uveitis is supported, and a median follow-up of 15 months shows 9 of 17 eyes had an improvement in visual acuity.